| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |